• 1. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 2. An atomic scale study of defects in Co2FeAl
  Ravi Kumar Yadav,R. Govindaraj Phys. Chem. Chem. Phys., 2020,22, 26876-26886
• 3. An antioxidant self-healing hydrogel for 3D cell cultures?
  Lei Yang,Yuan Zeng,Haibo Wu,Chunwu Zhou,Lei Tao J. Mater. Chem. B, 2020,8, 1383-1388
• 4. An atlas of endohedral Sc2S cluster fullerenes?
  Li-Hua Gan,Rui Wu,Jian-Lei Tian,Patrick W. Fowler Phys. Chem. Chem. Phys., 2017,19, 419-425
• 5. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Phenylpropylamines

Comprehensive Overview of 3-(4-fluoro-3-nitrophenyl)propan-1-amine (CAS No. 1000564-47-5): Properties, Applications, and Industry Insights

3-(4-fluoro-3-nitrophenyl)propan-1-amine (CAS No. 1000564-47-5) is a specialized organic compound gaining attention in pharmaceutical and agrochemical research due to its unique structural features. This fluoro-nitrophenyl derivative combines a propan-1-amine backbone with a nitro-substituted aromatic ring, making it a versatile intermediate for synthesizing bioactive molecules. Researchers are particularly interested in its potential as a building block for drug discovery, especially in developing kinase inhibitors and antimicrobial agents.

The compound's molecular structure (C9H11FN2O2) features a fluorine atom at the para position and a nitro group at the meta position of the phenyl ring, which significantly influences its electronic properties and reactivity. These characteristics make it valuable for structure-activity relationship (SAR) studies in medicinal chemistry. Recent publications highlight its use in creating targeted therapies for various diseases, aligning with the growing trend of precision medicine in healthcare.

From a synthetic chemistry perspective, 3-(4-fluoro-3-nitrophenyl)propan-1-amine serves as a crucial intermediate in multi-step organic synthesis. Its amine functionality allows for easy derivatization through amide formation or reductive amination, while the nitro group can be reduced to an amino group for further modifications. This flexibility addresses the pharmaceutical industry's need for diverse chemical scaffolds in high-throughput screening programs.

Environmental and green chemistry considerations have prompted investigations into sustainable production methods for this compound. Researchers are exploring catalytic processes and solvent-free reactions to minimize waste generation, responding to the chemical industry's shift toward eco-friendly manufacturing. The compound's stability under various conditions also makes it suitable for long-term storage and global distribution, important factors for international research collaborations.

Analytical characterization of CAS No. 1000564-47-5 typically involves advanced techniques such as HPLC-MS, NMR spectroscopy, and X-ray crystallography. Quality control protocols emphasize purity assessment due to its application in biological testing. The compound's spectral data and physicochemical properties (including melting point, solubility, and partition coefficient) are well-documented in scientific literature, facilitating its adoption by research teams worldwide.

Emerging applications of 3-(4-fluoro-3-nitrophenyl)propan-1-amine extend to material science, where its aromatic amine structure contributes to developing advanced polymers and functional coatings. The electron-withdrawing nitro group and fluorine substitution pattern offer unique opportunities for creating materials with tailored electronic properties, relevant to organic electronics and sensor technologies.

Safety assessments indicate that proper handling procedures should be followed when working with this compound, including the use of personal protective equipment and adequate ventilation. While not classified as highly hazardous, standard laboratory precautions for nitroaromatic compounds apply. These safety considerations align with the pharmaceutical industry's increasing focus on occupational health and process safety in research and development.

The commercial availability of 3-(4-fluoro-3-nitrophenyl)propan-1-amine from specialty chemical suppliers has increased significantly in recent years, reflecting growing demand from contract research organizations and academic institutions. Pricing trends and supply chain dynamics for this intermediate are influenced by factors such as raw material availability and regulatory requirements in different markets.

Future research directions for this compound include exploring its potential in bioconjugation chemistry and developing more efficient synthetic routes. The scientific community continues to investigate its structure-property relationships to unlock new applications in life sciences and advanced materials. As the demand for specialty chemical intermediates grows, compounds like 3-(4-fluoro-3-nitrophenyl)propan-1-amine will play increasingly important roles in innovation across multiple industries.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)